NYSE:CLDI | Profit Breakdown | Calidi Biotherapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-06-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$4.15M-$4.16M-$4.16M
2026-03-31-$4.19M-$4.1M-$4.11M
2025-12-31-$4.47M-$4.06M-$4.06M
2025-09-30-$5.05M-$5.17M-$5.15M
2025-06-30-$5.66M-$5.76M-$5.72M
2025-03-31-$5.06M-$5.06M-$4.99M
2024-12-31-$4.03M-$4.15M-$4.1M
2024-09-30-$5.23M-$5.07M-$5.05M
2024-06-30-$5.77M-$5.76M-$5.77M
2024-03-31-$6.75M-$7.22M-$7.23M
2023-12-31-$9.82M-$8.23M-$8.23M
2023-09-30-$7.22M-$2.01M-$2.02M
2023-06-30-$6.54M-$12.5M-$12.5M
2023-03-31-$5.41M-$6.46M-$6.46M
2022-12-31$0.00-$4.69M-$7.76M-$7.76M
2022-09-30-$6.99M-$5.35M-$5.36M
2022-06-30-$361,622.00$4.16M-$4.58M
2022-03-31-$528,858.00$1.46M-$7.74M
2021-09-30-$1.09M-$823,289.00-$823,289.00
2021-06-30-$83,303.00-$83,303.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$20.24M-$20.05M-$19.91M
2024-12-31-$21.78M-$22.2M-$22.14M
2023-12-31-$28.99M-$29.2M-$29.22M
2022-12-31$45,000.00-$23.13M-$25.42M-$25.43M